NEURONTIN(GABAPENTIN) - 美国FDA药品数据库

与本品相关的专利信息（来自橙皮书Orange Book）
专利号	专利过期日	是否化合物专利	是否产品专利	专利用途代码	专利下载
6054482	2017/04/25				PDF格式
6054482*PED	2017/10/25				PDF格式
历史专利信息
4894476	2008/05/02				PDF格式
4894476*PED	2008/11/02				PDF格式

药品注册审批历史信息
申请号	修订号	审批结论	审批日期	审批内容
020235	061	AP	2015/04/21	Labeling Revision
020235	060	AP	2015/09/14	Labeling Revision
020235	057	AP	2014/08/18	Labeling Revision
020235	056	AP	2013/05/01	Labeling Revision
020235	055	AP	2013/05/01	Labeling Revision
020235	054	AP	2013/05/01	Labeling Revision
020235	050	AP	2011/08/10	Labeling Revision
020235	043	AP	2010/10/11	Labeling Revision
020235	041	AP	2009/04/23	Labeling Revision
020235	036	AP	2011/03/01	Labeling Revision
020235	035	AP	2006/05/03	Labeling Revision
020235	029	AP	2005/02/18	Labeling Revision
020235	026	AP	2002/12/19	Control Supplement
020235	024	AP	2002/10/24	Manufacturing Change or Addition
020235	023	AP	2002/08/15	Efficacy Supplement with Clinical Data to Support
020235	022	AP	2002/01/30	Labeling Revision
020235	021	AP	2002/01/18	Control Supplement
020235	020	AP	2001/02/08	Manufacturing Change or Addition
020235	019	AP	2001/02/08	Manufacturing Change or Addition
020235	018	AP	2001/01/18	Manufacturing Change or Addition
020235	017	AP	2000/08/16	Manufacturing Change or Addition
020235	016	AP	2000/07/21	Control Supplement
020235	015	AP	2000/10/12	New or Modified Indication
020235	014	AP	2000/05/15	Manufacturing Change or Addition
020235	011	AP	1998/09/29	New Dosage Regimen
020235	009	AP	1998/02/12	Manufacturing Change or Addition
020235	005	AP	1996/12/09	Manufacturing Change or Addition
020235	004	AP	1996/05/28	Manufacturing Change or Addition
020235	003	AP	1996/04/09	Package Change
020235	001	AP	1994/11/14	Labeling Revision
020235	000	AP	1993/12/30	Approval